mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.3 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |